Associated Papers
Genomic Characterization of Preclinical Prostate Cancer Cell Line Models.
Beatson EL et al.
International Journal of Molecular Sciences, 2024
ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk.
Stolarova L et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2023
AR phosphorylation and CHK2 kinase activity regulates IR-stabilized AR-CHK2 interaction and prostate cancer survival.
Ta HQ et al.
Elife, 2020
Genomic analysis of DNA repair genes and androgen signaling in prostate cancer.
Jividen K et al.
Bmc Cancer, 2018
30305041 (PubMed )
Supplement: 12885_2018_4848_MOESM1_ESM.xlsx › Sheet1
Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines.
Wasielewski M et al.
Breast Cancer Research and Treatment, 2009
Unique substitution of CHEK2 and TP53 mutations implicated in primary prostate tumors and cancer cell lines.
Zheng L et al.
Human Mutation, 2006
Select a paper to view details